News | December 08, 2021
Healthium Medtech Sri City facility in AP gets U.S. FDA registration
This is the fourth facility from the company to receive this registration
This is the fourth facility from the company to receive this registration
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Viyash has ten manufacturing facilities in India with a combined capacity of 2000 KL as well as one formulation facility in the US, and is now one of India’s leading mid-tier integrated API and formulation players
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
The first clinical trial is expected to commence in early 2022 both in Europe and the US
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others
Subscribe To Our Newsletter & Stay Updated
